We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$3.84B
AUM Growth
-$2.1B
Cap. Flow
-$2.45B
Cap. Flow %
-63.69%
Top 10 Hldgs %
22.61%
Holding
6,382
New
824
Increased
1,880
Reduced
2,765
Closed
701

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$120M
2
MSFT icon
Microsoft
MSFT
+$115M
3
IWM icon
iShares Russell 2000 ETF
IWM
+$72.4M
4
AMZN icon
Amazon
AMZN
+$69.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$51.2M

Sector Composition

Rank Sector Weight
1 Technology 19.05%
2 Consumer Discretionary 11.67%
3 Healthcare 9.59%
4 Financials 9.24%
5 Communication Services 7.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LVOX
4251
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
$13K ﹤0.01%
+1,520
New +$15K
NEWR
4252
DELISTED
New Relic, Inc.
NEWR
$13K ﹤0.01%
192
-428
-69% -$27.6K
WTT
4253
DELISTED
Wireless Telecom Group, Inc.
WTT
$13K ﹤0.01%
3,147
+2,076
+194% +$4.04K
SGTX
4254
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$13K ﹤0.01%
97
+33
+52% +$5.8K
SEAC
4255
DELISTED
Seachange International Inc
SEAC
$13K ﹤0.01%
512
-305
-37% -$7.19K
GACQU
4256
DELISTED
Global Consumer Acquisition Corp. Unit
GACQU
$13K ﹤0.01%
+1,348
New +$13.4K
SWT
4257
DELISTED
Stanley Black & Decker, Inc.
SWT
$13K ﹤0.01%
107
-1,866
-95% -$228K
PHAS
4258
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$13K ﹤0.01%
3,565
-131
-4% -$436
ASAQ
4259
DELISTED
Atlantic Avenue Acquisition Corp
ASAQ
$13K ﹤0.01%
1,319
+569
+76% +$5.55K
CTEK
4260
DELISTED
CynergisTek, Inc.
CTEK
$13K ﹤0.01%
6,573
+5,380
+451% +$10.1K
ICBK
4261
DELISTED
County Bancorp, Inc. Common Stock
ICBK
$13K ﹤0.01%
393
-278
-41% -$7K
ALUS
4262
DELISTED
Alussa Energy Acquisition Corp
ALUS
$13K ﹤0.01%
1,325
+625
+89% +$6.25K
PLM
4263
DELISTED
PolyMet Mining Corp.
PLM
$13K ﹤0.01%
+3,773
New +$11.9K
AEHR icon
4264
Aehr Test Systems
AEHR
$3.46B
$12K ﹤0.01%
4,379
-3,274
-43% -$7.83K
AEYE icon
4265
AudioEye
AEYE
$73.2M
$12K ﹤0.01%
708
-456
-39% -$9.52K
APM
4266
DELISTED
Aptorum Group
APM
$12K ﹤0.01%
+384
New +$10.8K
FRMM
4267
Forum Markets
FRMM
$83.2M
0
BSY icon
4268
Bentley Systems
BSY
$10.7B
$12K ﹤0.01%
182
-1,918
-91% -$105K
CBFV icon
4269
CB Financial Services
CBFV
$190M
$12K ﹤0.01%
562
-482
-46% -$10.5K
CCU icon
4270
Compañía de Cervecerías Unidas
CCU
$2.24B
$12K ﹤0.01%
+598
New +$11.1K
CPHC icon
4271
Canterbury Park Holding Corp
CPHC
$79.6M
$12K ﹤0.01%
826
-415
-33% -$5.87K
DUST icon
4272
Direxion Daily Gold Miners Index Bear 2X ETF
DUST
$49.9M
$12K ﹤0.01%
6
+1
+20% +$1.72K
ENVB icon
4273
Enveric Biosciences
ENVB
$6.2M
$12K ﹤0.01%
+1
New +$21.4K
EPM icon
4274
Evolution Petroleum
EPM
$134M
$12K ﹤0.01%
2,448
-4,626
-65% -$18.2K
GFI icon
4275
Gold Fields
GFI
$36.8B
$12K ﹤0.01%
+1,343
New +$13.9K

Similar funds

Tower Research Capital (TRC)'s Q2 2021 Portfolio in Review

As of Q2 2021, Tower Research Capital (TRC) held 6,382 positions worth $3.84B, down 35% from $5.94B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Tower Research Capital (TRC) withdrew a net $2.45B in Q2 2021, closing 701 positions and reducing 2,765 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $15.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in Invesco NASDAQ Biotechnology ETF worth $8.44M.

  • Tower Research Capital (TRC)'s largest Q2 2021 buy was Invesco NASDAQ Biotechnology ETF: 325,629 shares worth $8.44M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $175M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2021 reduction was Apple, cutting an estimated $120M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q2 2021, selling an estimated $15.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 23% of its $3.84B portfolio in Q2 2021.
  • Tower Research Capital (TRC) opened 824 new positions and closed 701 in Q2 2021.
  • Tower Research Capital (TRC)'s portfolio value fell 35% quarter-over-quarter to $3.84B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2021, filed 16 Aug 2021.